Full-Time

Controller / Director of Accounting

Posted on 4/17/2026

Arine

Arine

201-500 employees

Data-driven medication management for providers

Compensation Overview

$180k - $200k/yr

San Francisco, CA, USA

Hybrid

Two days in-office per week.

Category
Accounting (1)
Required Skills
NetSuite
Requirements
  • 10+ years of progressive accounting experience, including at least 3 years in a supervisory or management role
  • CPA required
  • Deep knowledge of US GAAP, including technical accounting areas such as revenue recognition (ASC 606), stock-based compensation (ASC 718), and lease accounting (ASC 842)
  • Experience managing external audits from planning through completion
  • Hands-on experience with NetSuite or comparable ERP systems
Responsibilities
  • Own the monthly close process, ensuring accurate and timely financial statements in accordance with US GAAP
  • Ensure timely and accurate customer invoicing aligned to contract terms, revenue recognition under ASC 606, and monthly revenue forecasting
  • Monitor cash position, manage cash flow forecasting, and oversee banking relationships
  • Prepare and review journal entries, account reconciliations, and flux analyses
  • Produce board-ready financial reporting packages and support investor and lender reporting requirements
  • Manage technical accounting matters including ASC 606 (revenue recognition for SaaS contracts), ASC 718 (stock-based compensation), and ASC 842 (leases); support equity transaction accounting and cap table reconciliation
  • Serve as the primary point of contact for external auditors and manage the annual audit process from planning through completion
  • Coordinate with external tax advisors on federal and multi-state income tax filings, R&D tax credits, sales tax compliance, and payroll tax matters across all states where Arine operates
  • Ensure compliance with all regulatory and statutory reporting requirements
  • Own the accounting technology stack, including NetSuite (ERP), Rippling (payroll and expense management), Tipalti (AP), and supporting integrations
  • Identify and implement process improvements and automation opportunities across the accounting function, in particular related to revenue recognition and forecasting in collaboration with FP&A
  • Develop and maintain accounting policies and procedures that scale with the business
  • Design, document, and maintain internal controls over financial reporting appropriate for a growth-stage company
  • Manage and develop team members
  • Set clear expectations, provide regular feedback, and invest in the professional growth of each team member
  • Partner cross-functionally with FP&A, People Operations, Clinical Operations, and Client Success to support company initiatives
Desired Qualifications
  • Public accounting experience (Big 4 or national firm) strongly preferred
  • Healthcare industry experience is a plus but not required
  • Prior experience at a venture-backed, high-growth technology or SaaS company preferred
  • Comfortable leveraging AI (Claude, Gemini, etc.) to increase productivity
  • Excellent written and verbal communication skills; you can explain technical accounting concepts to non-finance stakeholders
  • Self-starter who thrives in a fast-paced, resource-constrained environment and is comfortable operating as both a leader and an individual contributor

Arine provides a data-driven platform for medication management in healthcare. It analyzes patient health data to offer personalized MTM, medication intelligence, and optimization through a subscription for providers, insurers, and health plans. The goal is to improve patient outcomes while reducing costs, by ensuring safe and effective medication use for older adults and those with complex regimens. It differentiates itself by focusing on personalized, evidence-based MTM and measurable care-quality improvements like CAHPS and Star ratings.

Company Size

201-500

Company Stage

Series C

Total Funding

$70M

Headquarters

San Francisco, California

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Series C $30M from Town Hall Ventures expands specialty pharmacy AI in 2025.
  • Inc. 5000 recognition and 100% retention boost Star ratings for clients.
  • CMS MTM evolution favors Arine's automated reviews and real-time reporting.

What critics are saying

  • CoverMyMeds automates priors for 80M patients, erodes Arine's payer share.
  • CMS 2026 expands MTM to telepharmacy, slashing Priority Health retention.
  • Epic MyChart captures 70% hospital referrals, blocks Arine's provider pipeline.

What makes Arine unique

  • Arine merges AI with pharmacotherapy expertise for personalized MTM.
  • Platform analyzes claims, clinical, and SDOH data for precise interventions.
  • Delivers 40% hospitalization reduction and 10% cost savings across 30M lives.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Arine who can refer or advise you

Benefits

Remote Work Options

Professional Development Budget

Company News

FinSMEs
Jun 24th, 2025
Arine Raises $30M in Series C Funding

Arine, a San Francisco, CA-based AI-driven medication intelligence company, raised $30M in Series C funding.

StreetInsider
Jun 24th, 2025
Arine Secures $30M for AI Medication Optimization

Arine, a leader in AI-driven medication optimization, announced a $30 million Series C funding round led by Town Hall Ventures, with participation from Kaiser Permanente Ventures. This brings Arine's total funding to $66 million. The funds will help Arine expand its platform's capabilities, focusing on specialty pharmacy management and AI innovation to enhance patient care and cost savings. Arine has achieved over 10% cost savings and 40% reduction in hospitalizations.

PR Newswire
Jun 24th, 2025
Arine Raises Series C to Scale AI-Driven Medication Optimization and Power Value-Based Outcomes

/PRNewswire/ -- Today Arine, the leader in AI-driven medication intelligence, announced a Series C funding round. Town Hall Ventures, known for backing...

HIT Consultant
Jun 24th, 2025
Arine Raises $30M to Redefine Medication Management with AI

- Arine, the leader in AI-driven medication intelligence announced it has closed a $30M Series C funding round led by Town Hall Ventures, with participation from Kaiser Permanente Ventures and other existing investors.

HIT Consultant
Jan 15th, 2025
Overprescribing And Polypharmacy: Arine Ceo Talks The Hidden Dangers Of Amazon’S Same-Day Prescription Delivery

Yoona Kim, Founder CEO at ArineAs ultra-fast prescription delivery services reshape medication access, healthcare providers face an urgent challenge: balancing patient convenience with medication safety. With 1 in 5 adults using five or more prescription drugs and medication-related problems consuming 1 in 6 healthcare dollars ($528B annually), the stakes are high.In this interview, Yoona Kim, CEO of healthcare AI company Arine discusses how the evolution of prescription delivery services, while improving access, may inadvertently contribute to dangerous polypharmacy and medication mismanagement. She comments on the critical challenges facing healthcare providers, from fragmented medication tracking to rapidly evolving drug knowledge, and explores how AI-powered solutions can help ensure safe, effective medication management in an increasingly automated healthcare landscape.What are the potential benefits and risks of ultra-fast prescription delivery services like Amazon Pharmacy’s same-day delivery? How can these services impact patient access to medications and adherence to treatment plans?Yoona Kim, Founder CEO at Arine: Ultra-fast prescription delivery services like Amazon Pharmacy’s same-day delivery offer clear benefits to patients, particularly those with acute health needs. Instead of having to pick up medication from the pharmacy – while potentially feeling under the weather – patients can have medications delivered straight to their door within hours. It’s easy to see why this level of convenience is appealing, especially as we grow accustomed to rapid delivery in other areas of our lives, such as grocery shopping.However, this convenience comes with considerable risks in our already fragmented healthcare ecosystem. To start, it complicates providers’ ability to track a patient’s medications

INACTIVE